In addition to breast cancer cells, adiponectin was found to suppress inflammasomes activation in human hepatocarcinoma cancer cells (Figure 1), suggesting that inflammasomes modulation might be a common response by adiponectin in various cancer cells. This evidence concerns the gene ADIPOQ and breast cancer.